MedTrace Logo

The RODEO Micro Mapping Catheter in Cryoablation Procedures

NCT04845750 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2022-07-21

No results posted yet for this study

Summary

This clinical investigation evaluates the feasibility of the Rodeo Micro Mapping Catheter in combination with cryoablation ssystem (sclerotherapy of muscle tissue of the heart by freezing) in patients with atrial fibrillation (permanent atrial fibrillation excepted).

Further aims of this study are the evaluation of safety of the device and average procedure and fluoroscopy times.

Conditions

Interventions

DEVICE

Rodeo Micro Mapping Catheter

The Rodeo Micro Mapping Catheter is used during cryoablation of atrial fibrillation patients for determination of pulmonary vein isolation

Sponsors & Collaborators

  • Competence Center for Medical Devices GmbH

    collaborator UNKNOWN

  • afreeze GmbH

    lead OTHER

Principal Investigators

  • Florian Hintringer, MD · Medizinische Universität Innsbruck

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-14
Primary Completion
2022-12-31
Completion
2023-01-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845750 on ClinicalTrials.gov